GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Market Cap

Laurus Labs (BOM:540222) Market Cap : ₹330,993 Mil (As of Mar. 29, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Laurus Labs's share price for the quarter that ended in Dec. 2024 was ₹602.35. Laurus Labs's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 539 Mil. Therefore, Laurus Labs's market cap for the quarter that ended in Dec. 2024 was ₹324,818 Mil.

Laurus Labs's quarterly market cap increased from Jun. 2024 (₹228,738 Mil) to Sep. 2024 (₹249,496 Mil) and increased from Sep. 2024 (₹249,496 Mil) to Dec. 2024 (₹324,818 Mil).

Laurus Labs's annual market cap declined from Mar. 2022 (₹317,069 Mil) to Mar. 2023 (₹157,825 Mil) but then increased from Mar. 2023 (₹157,825 Mil) to Mar. 2024 (₹211,140 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Laurus Labs's Enterprise Value for Today is ₹358,467 Mil.


Laurus Labs Market Cap Historical Data

The historical data trend for Laurus Labs's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Market Cap Chart

Laurus Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34,490.59 194,276.75 317,068.68 157,824.74 211,139.93

Laurus Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 231,836.22 211,139.93 228,738.21 249,495.83 324,818.44

Competitive Comparison of Laurus Labs's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Market Cap distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Market Cap falls into.


;
;

Laurus Labs Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Laurus Labs's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹391.75*538.966
=₹211,140

Laurus Labs's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₹602.35*539.252
=₹324,818

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laurus Labs  (BOM:540222) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Laurus Labs Market Cap Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs Headlines

No Headlines